Lotemax and endophthalmitis Patient Reports February 13, 2012
Lotemax Side Effects Report #4738539-1
Lotemax side effect was reported by a Physician from GERMANY on July 18, 2005. Female patient, 92 years of age, was diagnosed with inflammation, post procedural complication and was treated with Lotemax. After drug was administered, patient experienced the following side effects: endophthalmitis, eye disorder, macular oedema, visual acuity reduced. Lotemax dosage: unknown. Patient was hospitalized. Patient recovered.
Lotemax Side Effects Report #4709357-5
Lotemax side effect was reported by a Physician from GERMANY on June 20, 2005. Female patient, 76 years of age, weighting 152.1 lb, was diagnosed with inflammation and was treated with Lotemax. After drug was administered, patient experienced the following side effects: endophthalmitis. Lotemax dosage: unknown. During the same period patient was treated with FLOXAL AUGENTROPFEN, FLOXAL AUGENSALBE, DURANITRAT, NIFEHEXAL, URBASON, RIOPAN, PANTOZOL. Patient was hospitalized. Patient recovered.
Lotemax Side Effects Report #4599051-6
Lotemax side effect was reported by a Health Professional from on Feb 17, 2005. Female patient, 92 years of age, was diagnosed with cataract operation and was treated with Lotemax. After drug was administered, patient experienced the following side effects: adverse event, endophthalmitis. Lotemax dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
Lotemax Side Effects Report #4627352-1
Lotemax side effect was reported by a Physician from on Mar 15, 2005. Female patient, 92 years of age, was diagnosed with cataract operation and was treated with Lotemax. After drug was administered, patient experienced the following side effects: application site reaction, endophthalmitis, visual acuity reduced. Lotemax dosage: unknown. Patient was hospitalized. Patient recovered.
Lotemax Side Effects Report #4627363-6
Lotemax side effect was reported by a Physician from on Mar 15, 2005. Female patient, 76 years of age, weighting 152.1 lb, was treated with Lotemax. After drug was administered, patient experienced the following side effects: endophthalmitis. Lotemax dosage: unknown. During the same period patient was treated with FLOXAL AUGENTROPFEN, FLOXAL AUGENSALBE, DURANITRAT, NIFEHEXAL, URBASON, RIOPAN, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.
Lotemax and endophthalmitis 